CRISPR Gene Editing Newsletter
Issue #35May 4, 20267 studies

CRISPR-Cas12a can now be guided by DNA instead of RNA to target RNA molecules

This week brought major advances in genome editing precision and efficiency, from new ways to insert large DNA sequences without breaking chromosomes to reprogramming CRISPR systems in unexpected ways.

🧬 Scientists flip CRISPR-Cas12a inside out—now DNA guides target RNA

  • Researchers reprogrammed CRISPR-Cas12a to use DNA guides instead of RNA guides, while targeting RNA molecules instead of DNA

  • This flipped configuration enables direct RNA detection and efficient RNA knockdown inside cells

  • Structural and biochemical analyses reveal this DNA-guided system works through a completely different activation pathway than normal RNA-guided CRISPR

Why it matters: This breakthrough expands what CRISPR can do by creating modular systems that could lead to new RNA-targeting therapies and diagnostics.

🏆 Top 0.1% journal 🔗 Nature biotechnology Journal Article 🗓️ May 1

Key Findings

🎯 New prime editing method inserts DNA up to 11 kb without chromosome breaks

  • Prime assembly (PA) successfully inserted DNA fragments ranging from 0.1 kb to 11 kb using overlapping DNA templates

  • The method works in non-dividing cells and doesn't require DNA repair pathways or external enzymes

  • Adding an inhibitor of DNA repair improved both efficiency and precision of large insertions

💡 This could enable safer gene therapies by avoiding the chromosome damage that current methods cause.
🔗 Nature Journal Article 🗓️ Apr 29

🧪 Gene editing achieves 50% efficiency in human T cells without toxic DNA breaks

  • PRIME-In technology reached up to 50% integration efficiency for a 3-kb CAR construct in primary human T cells

  • The method eliminated detectable chromosome abnormalities compared to traditional DNA break-dependent approaches

  • Enhanced editing used single or paired genomic nicks instead of double-strand breaks, reducing cell toxicity

💡 This safer approach could streamline manufacturing of CAR-T cell immunotherapies.
🥇 Top 1% journal 🔗 Nature biomedical engineering Journal Article 🗓️ Apr 30

🌾 Sweet potato gene knockout creates amylose-free starch without yield loss

  • CRISPR knockout of all six copies of the IbGBSS1 gene in hexaploid sweet potato reduced amylose content to less than 1%

  • Modified plants showed normal growth and unchanged yield under both greenhouse and field conditions

  • The amylose-free starch had larger granules and different properties useful for food and industrial applications

💡 This demonstrates that complex crops can be precisely engineered for valuable traits without sacrificing productivity.

🦠 Anti-CRISPR protein destroys Cas12a by targeting its mRNA during translation

  • The anti-CRISPR protein AcrVA2 binds to ribosomes and triggers selective degradation of cas12a mRNA as it's being translated

  • This represents a completely new mechanism for how viruses can disable bacterial CRISPR defenses

  • The protein's C-terminal domain enables it to associate with ribosomes and polysomes for targeted mRNA destruction

💡 This reveals how the evolutionary arms race between bacteria and viruses has produced sophisticated molecular sabotage.
🔗 Nature Journal Article 🗓️ Apr 29

🔬 Base editing couples disease treatment with cell amplification in blood disorders

  • Multiplex base editing of blood stem cells increased both fetal hemoglobin expression and red blood cell production

  • The approach combined therapeutic edits with a fitness-enhancing mutation that boosted erythroid cell numbers

  • Edited cells retained long-term repopulation capacity and showed synergistic effects beyond single edits

💡 This strategy could amplify therapeutic benefits by linking disease correction to selective advantages for treated cells.

🌽 Knocking out one gene protects maize from lethal viral disease

  • CRISPR knockout of the MLNS1 gene in elite maize lines provided field resistance comparable to naturally resistant varieties

  • The gene encodes a peroxisomal enzyme, revealing an unexpected link between cellular metabolism and viral susceptibility

  • Edited plants showed no yield penalty or growth defects under disease-free conditions in Kenya field trials

💡 This demonstrates how single gene edits can rapidly transfer disease resistance to valuable crop varieties.
🔗 Proc Natl Acad Sci U S A Journal Article 🗓️ Apr 30

Implications

These advances show genome editing is becoming both more precise and more versatile—from safely inserting large DNA sequences to completely reprogramming how CRISPR systems work. The field is moving toward therapies and crops that can be engineered with minimal side effects while achieving complex biological goals.

Studies in this issue

Primary sources used for this newsletter.

  1. DNA-guided CRISPR-Cas12a tools for targeted RNA detection and cutting
    main storyNature biotechnology2026-05-01PMID 42067668
  2. Anti-CRISPR triggers breakdown of cas12 mRNA during its protein production
    key findingNature2026-04-29PMID 42056528
  3. Precise insertion of large DNA into human T cells without cutting their DNA
    key findingNature biomedical engineering2026-04-30PMID 42062564
  4. Removing a specific cell enzyme in maize helps resist lethal necrosis disease
    key findingProceedings of the National Academy of Sciences of the United States of America2026-04-30PMID 42060714
  5. Removing a Key Gene in Sweet Potato Produces Starch Without Amylose Without Reducing Crop Yield
    key findingPlant science : an international journal of experimental plant biology2026-05-01PMID 42066814
  6. Using combined gene editing to fix disease and increase growth in blood-forming stem cells
    key findingbioRxiv : the preprint server for biology2026-04-27PMID 42039379
  7. Using prime assembly with linear DNA to insert large genetic sequences
    key findingNature2026-04-29PMID 42056515

Continue reading

All CRISPR Gene Editing issues